Roxyfoli 50 Tablet contains Roxithromycin 50mg, a macrolide antibiotic formulated to treat respiratory tract infections, pharyngitis, tonsillitis, skin infections, and other bacterial infections. It helps in controlling bacterial growth and reducing infection severity.
Roxithromycin works by inhibiting bacterial protein synthesis, providing effective antimicrobial activity with minimal side effects. Its tablet form ensures accurate dosing, patient-friendly administration, and better adherence.
Widely prescribed in clinics, hospitals, and pharmacies, Roxyfoli 50 Tablet is a high-demand anti-infective product for all age groups.
Adding Roxyfoli 50 Tablet to your anti-infective portfolio enhances your offerings with a fast-moving, clinically trusted therapy. Its prescriber confidence, institutional use, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.